JANUARY 30, 2015
President Obama hosts a White House event today to unveil his new “Precision Medicine Initiative.”
The event kicks off today at 11 AM Eastern, and will feature “patients, researchers, clinicians and leaders in government and industry to announce details of his new Precision Medicine Initiative,” according to White House spokesman Josh Earnest.
The proceedings will be streamed live at www.whitehouse.gov/live starting at 11:10 AM Eastern.
- White House Blog: Data-Driven Treatments as Unique as Your Own Body
- National Institutes of Health: Precision Medicine Initiative
- Fact Sheet: President Obama’s Precision Medicine Initiative
- Commentary: NEJM – A New Initiative on Precision Medicine by NIH director Dr. Francis Collins and NCI Director Dr. Harold Varmus
- NCI Blog: Precision Medicine Cancer Research
Precision Medicine Initiative
“Precision medicine,” also referred to as “Personalized Medicine,” leverages genetic screening, molecular diagnostic tests, big data computer science, biostatistics, and other fields to provide medical insight and cross-reference individual health information with global health, clinical study, and population information.
At the State of the Union address delivered on January 20, 2015, the President committed his administration to launching a patient-specific precision medicine initiative to “bring us closer to curing diseases like cancer and diabetes – and to give all of us access to the personalized information we need to keep ourselves and our families healthier.”
“Precision Medicine Initiative” will build a comprehensive scientific knowledge base to put precision medicine into practice. The new biobank will have each voluntary participant share their genomic information, biological specimens, and include consented clinical data including laboratory results, MRI scans, and lifestyle data. Such a repository will put the United States in line with other countries who have built population databases including the UK, Japan, and Iceland.
As outlined by Collins and Varmus, “The proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.” President Obama’s budget proposal, to be released on Monday, will include a proposed $215 million in initial funding for the initiative.
Attending the White House Event
Earlier this week, several large drug-makers received “mysterious invitations” to the White House meeting, asking for their “top researcher” to attend the event.
Attendees of the event are slated to include ASCO Chief Medical Officer (CMO) Dr. Richard Shilsky, UCSF vice chancellor of research Dr. Keith Yamamoto, and UCSF Neurotrauma expert Dr. Geoffrey Manley, Sharon Terry of the Genetic Alliance, Dr. Craig Venter of Human Longevity, Dr. Silvia Burwell of HHS, Dr. Francis Collins NIH, and Dr. Harold Varmus of the NCI. These healthcare leaders will join patients, academics, scientists, pharmaceutical, government leaders, and biomedical company officials at the rollout.
For those at home, watch the live stream: www.whitehouse.gov/live
Next up: Building the research repository
The NIH will be hosting a workshop on Building the Precision Medicine Cohort on February 11-12.